Author

Pengxia Zhang

Institution: Jiamusi University

Observed institution: Jiamusi University

ORCID: 0000-0003-0008-0357

Observed ORCID: 0000-0003-0008-0357

OpenAlex ID: A5013656976

PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer

2025 · Jiacheng Li, Jia Liu, et al. · Cell Communication and Signaling · 24

m6A-modified circXPO1 accelerates colorectal cancer progression via interaction with FMRP to promote WWC2 mRNA decay

2024 · Xiaowen Zhu, Pengxia Zhang · Journal of Translational Medicine · 18

Recent Advances in the Mechanisms and Applications of Astragalus Polysaccharides in Liver Cancer Treatment: An Overview

2025 · Wang Wang, Hanting Zhou, et al. · Molecules · 16

Synergistic ROS/enzyme dual-responsive oral drug delivery system: A novel multi-mechanistic platform for spatiotemporal control and overcoming drug resistance in colorectal cancer therapy

2025 · Weitong Sun, Bingbing Fan, et al. · Materials Today Bio · 16

ROS/Enzyme Dual-Responsive Drug Delivery System for Targeted Colorectal Cancer Therapy: Synergistic Chemotherapy, Anti-Inflammatory, and Gut Microbiota Modulation

2025 · Xin Zhang, Ruonan Lian, et al. · Pharmaceutics · 13

A dual chemical-photothermal drug delivery platform inhibits LPS-induced oxidative damage by suppressing the p38 MAPK pathway in cardiomyocytes

2025 · Xi Han, Yue Li, et al. · Arabian Journal of Chemistry · 1

Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib

2022 · Linlin Song, Qi Li, et al. · Applied Bionics and Biomechanics · 1

Works count: 8

Citation count: 89

H-index: 5

I10-index: 5